Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial

Autor:	Mónica Orozco-Carroll, Ana L. Pérez-Balbuena, Oscar Olvera-Montaño, Irene M Montoya-Sánchez, Miguel A Villanueva-Najera, Pedro Gómez-Bastar, M González-Lomelí, Laura I Sandoval-Delgadillo, Mauricio Casillas-Magallanes, Aldo A Oregon-Miranda, Laura R. Saucedo-Rodríguez, Juan Carlos Ochoa-Tabares, Alfredo Mora-González, Arieh R Mercado-Sesma, Leopoldo Martín Baiza-Durán, Juan H Páez-Garza, Alfredo Lizárraga-Corona
Rok vydání:	2018
Předmět:	0301 basic medicine Pharmacology Bacterial Conjunctivitis medicine.medical_specialty business.industry 030106 microbiology Gatifloxacin law.invention 03 medical and health sciences Ophthalmology chemistry.chemical_compound 0302 clinical medicine Randomized controlled trial chemistry law Moxifloxacin Internal medicine Pazufloxacin 030221 ophthalmology & optometry medicine Pharmacology (medical) Clinical efficacy business Ocular surface medicine.drug
Zdroj:	Journal of Ocular Pharmacology and Therapeutics. 34:250-255
ISSN:	1557-7732 1080-7683
Popis:	Purpose: The purpose of this study was to evaluate the clinical efficacy and safety of a novel ophthalmic solution of pazufloxacin on the ocular surface of patients with bacterial conjunct...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9601468fcac1e476efbe8f6028b70154 https://doi.org/10.1089/jop.2017.0056 Zobrazit plný text záznamu